LISAvienna: March newsletter published

Our newsletter keeps you up-to-date on the life sciences in Vienna. Today, we highlight news from acib, AOP Orphan, Ares Genetics, Boehringer Ingelheim, enGenes, Hookipa Pharma, Lexogen, Marinomed, Odelga med, Rudolf Heintel Medizintechnik, Sanochemia, Themis Bioscience, Uni Vienna and Valneva.

Ten times a year we share a selection of recent news with you and update you on key facts and figures on life sciences in Vienna. Furthermore, we include some information on funding and support opportunities as well as events in the newsletter.

NEW: We use a more focused template since January – feedback is welcome!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)